期刊
CHEMICAL COMMUNICATIONS
卷 -, 期 38, 页码 4628-4630出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/b811575c
关键词
-
资金
- EPSRC
- Merck Research Laboratories
- NIH [CA-93455]
- NATIONAL CANCER INSTITUTE [R01CA093455, R56CA093455] Funding Source: NIH RePORTER
A potent dictyostatin-discodermolide hybrid was designed and synthesised; it showed enhanced cell growth inhibitory activity relative to discodermolide in four human cancer cell lines including the Taxol-resistant NCI/ADR-Res cell line.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
